Newsletter | March 17, 2026

03.17.26 -- 5 QMS Blind Spots You Should Know About

SPONSOR

Webinar: Enhanced biotherapeutic protein expression using advanced vector systems

In recombinant protein manufacturing with GS-CHO cells, vector design at transfection sets the stage for titre, quality, and long-term stability. In this webinar, Lonza introduces GSquad® Pro, its next-generation expression vector platform featuring the high-performance LHP-1 promoter. Discover how data-driven insights into gene expression control are advancing CHO vector design, accelerating development timelines, and strengthening key biomanufacturing performance metrics. Click here to learn more.

FOCUS ON OUTSOURCING

5 QMS Blind Spots You Should Know About

Companies often underestimate the complexity of standing up an eQMS. These are five of the most common issues that lead to regulatory and GMP exposure risk.

5 Advantages Of Dual-Sourcing In Pharmaceutical Fill/Finish

Delve into the specific advantages of dual-sourcing in pharmaceutical fill/finish, exploring how this approach can bolster supply chain resilience, increase capacity, and accelerate commercialization.

Using Digital Tools In Process Development

Technology can transform the entire biopharma production process chain. Using integrated process models, machine learning, and genetic algorithms has made production faster and more efficient.

Getting To The Heart Of CDMO Tech Transfer Excellence

Discover five key factors that drive a seamless and efficient technology transfer, highlighting how a culture of technical expertise, customer focus, and operational flexibility is crucial to success.

Considerations When Choosing An Expression System For Your Product

See how, whether you’re trying to achieve speed and cost-effectiveness or higher yields and glycosylation capabilities, the right system can be tailored to meet the needs of each unique biologic.

Challenges Of Moving A Bioconjugate Candidate From Clinic To Market

Drug developers must successfully navigate the path to market, under the growing pressure of regulation and competition, and while carefully managing technical and financial risk.

The Conductor Behind Every Successful CDMO Program

Understand how elite CDMO project management acts as a conductor—integrating molecule expertise, rigorous readiness, and disciplined GMP execution to drive successful biologics manufacturing programs.

The Right Scale At The Right Time To Accelerate Your Market Supply

Gain insight into challenges in today’s changing market and solutions to help successfully develop and manufacture lifesaving products.

Trends Shaping The Future Of Cell And Gene Therapy Manufacturing

Examine how automation and digitalization are transforming cell and gene therapy with scalable, decentralized manufacturing and smarter market navigation.

Path To IND: AAV Transient Transfection, Producer Cell Line Platforms

The streamlined AAV transient transfection platform de-risks your path to IND and reduces complexity and timeline for lengthy process and analytical development.

OUTSOURCING SOLUTIONS

Plant 5 — Dream Plant: Within Your Reach. Built For Your Success. - Samsung Biologics

Biologics Discovery Capabilities - Curia

Analytical Services - August Bioservices

USP General Chapter 382: Health Inspired, Quality Driven - SGS

Global CDMO Services: Large Molecule Biologics, Advanced Therapies - AGC Biologics

Leveraging Biologics Analytical Services - Alcami

Path To First-In-Human - Thermo Fisher Scientific

Connect With Bioprocess Online: